CimziaActive Ingredient(s): Certolizumab Pegol
FDA Approved: * April 22, 2008
Pharm Company: * UCB INC
Certolizumab pegol, sold under the brand name Cimzia, is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-α) and is manufactured by UCB. It is on the World Health Organization's List of Essential Medicines. Co... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.